Diamond David 4
4 · RenovoRx, Inc. · Filed Oct 4, 2022
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Diamond David
Director
Transactions
- Award
Stock Option (right to buy)
2022-10-01+25,099→ 25,099 totalExercise: $2.02Exp: 2032-10-01→ Common Stock (25,099 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2022.